Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
Clinical trial NCT00935532 · COMPLETED
Trial details
- NCT number
- NCT00935532
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.